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Abstract 1 
A fully automated on-line solid-phase extraction-liquid chromatography–tandem 2 
mass spectrometry (SPE–LC–MS/MS) method has been developed for the 3 
determination of 13 cytostatics and 4 metabolites in aqueous matrices, including 4 
groundwater, surface water, and raw and treated wastewater. On-line SPE is performed 5 
by loading 5 mL of water sample at pH 2 through a PLRP-s cartridge. MS/MS is 6 
performed with an electrospray (ESI) interface operating in the positive ion mode and 7 
registering two selected reaction monitoring (SRMs) transitions per compound. 8 
Quantification is carried out by the isotope dilution method using 15 different isotope-9 
labelled compounds, specific for the target analytes, as internal standards (IS). The main 10 
advantages of the method are high sensitivity, with limits of determination in 11 
groundwater, surface water, and raw and treated wastewater below 5 ng L
-1
 for all 12 
compounds except for gemcitabine (6.9-9.3 ng L
-1
) , temozolomide (26-50 ng L
-1
), 13 
imatinib (80-180 ng L
-1
) and etoposide (38-65 ng L
-1
), repeatability, with relative 14 
standard deviations (RSDs) in most cases below 15%, and selectivity and reliability of 15 
results. The method is also fairly simple and fast, with an analysis time per sample 16 
(excluding the manual steps, i.e., sample filtration, pH adjustment, and addition of IS) 17 
of 40 min. Application of the method to influent wastewater samples collected daily 18 
during eight consecutive days from a wastewater treatment plant (WWTP) from 19 
Catalonia showed the presence of methotrexate, ifosfamide, capecitabine, tamoxifen and 20 
6(α)-hydroxypaclitaxel but at fairly low concentrations (up to 43 ng L-1). 21 
Keywords: Cytostatics; Water; Analysis; On-line SPE; LC-MS/MS 22 
 23 
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1. Introduction 24 
Cytostatic drugs are used in the chemotherapy of oncological patients [1]. The use 25 
of chemotherapy began in the 1940s with nitrogen mustards, which are extremely 26 
powerful alkylating agents, and antimetabolites. Since the early success of these initial 27 
treatments, a large number of additional anticancer drugs have been developed [2]. The 28 
Anatomical Therapeutic Classification (ATC) classifies them into five classes: L01A 29 
alkylating agents; L01B antimetabolites; L01C plant alkaloids and other natural 30 
products; L01D cytotoxic antibiotics and related substances; and L01X other 31 
antineoplastic agents [1,3]. These substances act by either inhibiting cell growth or 32 
directly killing cells but acting unselectively on both tumour and healthy cells [2,4-5]. 33 
Therefore, many antineoplastic agents have cytotoxic, mutagenic, carcinogenic, 34 
embryotoxic and/or teratogenic effects [5-7]. The alkylating agents chlorambucil, 35 
cyclophosphamide, etoposide, tamoxifen and melphalan have already been classified by 36 
the International Agency for Research on Cancer (IARC) as carcinogens in humans 37 
(group 1), and carmustin and cisplatin as presumable carcinogens (group 2A) [8]. 38 
Occupational exposure of health care workers to cytotoxic drugs has been studied 39 
intensively and has resulted in guidelines for the safe handling of these substances in 40 
many countries [9]. However, despite high safety standards traces of cytotoxic agents 41 
have been found in urine and blood of healthcare professionals [10-11], and monitoring 42 
studies in pharmacies and hospitals have revealed that contamination of the workplace 43 
occurs frequently [11-13]. Less attention has been paid to the effects of cytostatics on 44 
the environment where different sources like emissions from production sites, direct 45 
disposal of pharmaceuticals in households, or excretions of patients under medical 46 
treatment can contribute to its potential pollution. In fact, some cytostatics have been 47 
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detected in hospital wastewaters and even influent wastewaters at concentration levels 48 
varying from ng L
-1 
to µg L
-1
 [1,3-4,14-19].  49 
Consequently, the development of analytical methods for determination of 50 
anticancer drugs is of outmost importance. Most of the analytical methods published for 51 
environmental samples are limited to individual determinations of the most consumed 52 
anticancer drugs: cyclophosphamide and ifosfamide [15,17]. Other authors have 53 
published analytical methods for the determination of one or two cytostatic drugs [3-54 
4,16,18,20-22]
 
or various but belonging to the same family [3,16]. However, to get a 55 
wider picture of the potentially existing contamination, multi-compound methods 56 
addressing the analysis of various drugs from different families are desirable. Yin et al. 57 
[19,23] and Martin et al. [24] have developed two analytical methods for the 58 
simultaneous determination of 9 and 14 cytostatics, respectively. Both methods used 59 
solid phase extraction for preconcentration of the compounds prior to their 60 
determination by LC-MS/MS. Although SPE offers considerable advantages, it requires 61 
relatively large sample volumes (from 0.3 to 1 L), a moderate consumption (10 – 15 62 
mL) of organic solvents for analytes desorption from the cartridge, and possibly further 63 
clean-up to compensate for its limited selectivity when applied to wastewater. In recent 64 
years, on-line SPE has emerged as a powerful and reliable tool for sample treatment of 65 
complex environmental [25] and biota [26] matrices, since it allows reducing most 66 
problems associated with off-line sample preparation, such as time-consumption, 67 
contamination, procedural errors and risk of low recoveries. Conditioning, washing and 68 
elution steps can be performed automatically and some systems also permit to extract 69 
one sample while another one is being analysed [27]. To the best of our knowledge, on-70 
line SPE-LC-MS/MS has been only applied to the determination of two cytostatics 71 
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(cyclophosphamide and methotrexate), together with other organic contaminants, in 72 
drinking and surface water [28]; however, recoveries remained below 70% and the 73 
method was not validated in wastewater. Hence, it is important to optimize new 74 
analytical methods for the simultaneous determination of different cytotoxic agents. In 75 
addition to the parent compound, active metabolites should be included in the methods 76 
since these compounds can appear in the environment and might therefore contribute to 77 
the biotoxic and mutagenic potential effects in the environment.  78 
In this context, the aim of this work was to develop and validate a multiresidue 79 
method based on on-line SPE-LC-MS/MS for determination of 13 cytostatics 80 
(gemcitabine, temozolomide, methotrexate, irinotecan, imatinib, ifosfamide, 81 
cyclophosphamide, erlotinib, etoposide, doxorubicin, capecitabine, tamoxifen and 82 
paclitaxel) and 4 metabolites (hydroxymethotrexate, desmethyl-hydroxytamoxifen, 83 
hydroxytamoxifen and hydroxypaclitaxel) in water samples (groundwater, surface water 84 
and wastewater). To the best of our knowledge, temozolomide, imatinib, erlotinib, 85 
capecitabine, hydroxytamoxifen, desmethyl-hydroxytamoxifen and hydroxypaclitaxel 86 
have not been included in any previously optimized method for cytostatics in 87 
environmental samples. The analysis of other compounds at the same time than those 88 
above, i.e., with the same methodology, was initially attempted but without success due 89 
to their very different physical-chemical properties. These compounds are: 5-90 
fluorouracil, vinblastine, vincristine, vinorelbine, carboplatin and oxaliplatin.  91 
 92 
 93 
 94 
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2. Experimental 95 
2.1. Standards and solvents 96 
All solvents were of HPLC grade and all chemicals were of analytical reagent 97 
grade. 98 
Formic acid (98-100%), hydrochloric acid (HCl, 37%), methanol and ultrapure 99 
water were purchased from Merck (Darmstadt, Germany), while dimethyl sulfoxide 100 
(>99.9%) and sodium hydroxide (98%) were acquired from Aldrich (Milwaukee, WI, 101 
USA) and Carlo-Erba (Milan, Italy), respectively. 102 
Standards of cytostatic compounds: cyclophosphamide (CP), ifosfamide (IF), 103 
temozolomide (TMZ), methotrexate (MET),  hydroxymethotrexate (OH-MET), 104 
gemcitabine hydrochloride (GEM), capecitabine (CAP), etoposide (ETP), 6(α)-105 
hydroxypaclitaxel (OH-PAC), doxorubicin hydrochloride (DOX), imatinib mesylate 106 
(IMA), erlotinib hydrochloride (ERL), irinotecan hydrochloride trihydrate, tamoxifen 107 
citrate (TAM), endoxifen or 4-Hydroxy-N-desmethyl-tamoxifen (OH-D-TAM), and 108 
(Z)-4-hydroxytamoxifen (OH-TAM) were obtained from Santa Cruz Biotechnology 109 
(Heidelberg, Germany), and paclitaxel (PAC) was supplied by Aldrich at the highest 110 
available purity (>99%). The isotopically labelled standards: cyclophosphamide-d4, 111 
ifosfamide-d4, temozolomide-d3, methotrexate-methyl-d3, 7-hydroxymethotrexate-d3, 112 
gemcitabine-
13
C,
15
N2 hydrochloride, capecitabine-d11, etoposide-d3, paclitaxel-d5, 6α-113 
hydroxypaclitaxel-d5, N-desmethyl imatinib-d8, erlotinib-d6 hydrochloride, irinotecan-114 
d10 hydrochloride, 4-hydroxy-N-desmethyl-tamoxifen-d5, and 4-hydroxy-ethyl-115 
tamoxifen-d5 were purchased from Santa Cruz Biotechnology. 116 
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The selected cytostatics and metabolites are shown in Fig. 1, grouped into six 117 
families attending to their mode of action and chemical structure. The parent 118 
compounds were selected based on consumption data in the European Union (EU), and 119 
the metabolites on the basis of excretion rate and activity [7]. 120 
Individual solutions of each compound (ca. 1000 µg mL
-1
) and a mixture of them 121 
(ca. 25 µg mL
-1
) were prepared in dimethyl sulfoxide (DMSO) and stored in the dark at 122 
-20ºC.  123 
Different working standard solutions were made by appropriate dilution in HPLC 124 
water and immediately analyzed by LC/MS-MS. 125 
2.2. Safety considerations on cytostatic drugs handling 126 
As cytostatic drugs are highly toxic compounds, their handling requires strict 127 
safety precautions in order to guarantee the best possible protection of research workers. 128 
All stock solutions were prepared under a biological safety hood with laminar airflow, 129 
and an absorbent paper was used to protect the work surfaces. All disposable material 130 
that was in contact with tested compounds was treated as hazardous waste. 131 
2.3. Sample pre-treatment 132 
The method was optimized using groundwater, river water, and WWTP effluent 133 
and influent. Amber glass bottles were used for sample collection. Water samples were 134 
acidified to pH 2 with HCl and were filtered through 1 µm fiberglass filters from 135 
Whatman (Fairfield, Connecticut, USA) followed by 0.45 µm nylon membrane filters 136 
from Teknokroma (Barcelona, Spain). The extraction of the samples was always carried 137 
8 
 
out within 24 hours of collection to keep microbial degradation to a minimum. When 138 
this was not possible, samples were frozen at -20 °C until analysis. 139 
2.4. On-Line Solid-Phase Extraction 140 
Preconcentration of the samples and chromatographic separation was performed 141 
using an automated on-line SPE–LC device SymbiosisTM Pico from Spark Holland 142 
(Emmen, The Netherlands). The base of the Symbiosis
TM
 Pico system is a high-end 143 
HPLC system with a high performance injector that handles sample volumes from 10 144 
µL up to 10 mL fully automated. This equipment also counts with the Alias
TM
 145 
autosampler that includes positive headspace pressure, extensive wash routines and 2 146 
injection modes, off-line and on-line SPE. Off-line mode was only used in the 147 
optimization procedure to assess the recovery by comparing the peak areas obtained in 148 
the on-line analyses of spiked waters samples with those obtained from the injection of 149 
standard mixtures of the analytes in HPLC water at equivalent concentrations. 150 
Five different 10 mm x 2 mm i.d. disposable trace enrichment cartridges were 151 
evaluated for their efficiency in the on-line SPE of cytostatics from water: the polymeric 152 
cartridge PLRP-s (crosslinked styrene-dininylbenzene polymer, 15-25 µm particle size), 153 
a Hysphere Resin GP 10 cartridge (polydivinylbenzene, 40-90 µm particle size), an 154 
Isolute C18 (octadecyl-bonded silica cartridge, end-capped, 40-90 µm), an Isolute HCX 155 
(mixed mode, cation exchange, 40-90 µm), all provided by Spark Holland, and an Oasis 156 
HLB (macroporous copolymer of divinylbenzene and N-vinylpyrrolidone, 30 µm 157 
particle size and 10 mm x 1 mm i-d) from Waters Corporation (Milford, Massachusetts, 158 
USA). 159 
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In the optimized procedure, preconcentration of all samples, aqueous standard 160 
solutions, and blanks is performed using PLRP-s cartridges previously conditioned with 161 
1 mL of methanol and 1 mL of water (flow rate 5 mL min
-1
). Loading of the sample (5 162 
mL) and subsequent washing of the cartridge with 0.5 mL of HPLC water is performed 163 
at a flow rate of 1 mL min
-1
. Upon completion of each SPE protocol, which takes place 164 
in the left clamp of the Symbiosis Pico, the cartridge is moved to the right clamp where 165 
the trapped analytes are eluted to the LC column with the chromatographic mobile 166 
phase. Meanwhile, a new cartridge is placed in the left clamp where preconcentration of 167 
the next sample in a sequence takes place. Therefore, SPE is carried out entirely in 168 
parallel with the LC-MS/MS run. This kind of configuration allows shortening the cycle 169 
time, which in our approach is 40 min/sample. 170 
2.5. LC-MS/MS analysis conditions 171 
LC-MS/MS analyses were carried out connecting in series the Symbiosis
TM
 Pico 172 
with a 4000QTRAP hybrid triple quadrupole-linear ion trap mass spectrometer 173 
equipped with a Turbo Ion Spray source from Applied Biosystems-Sciex (Foster City, 174 
California, USA). 4000QTrap is controlled by means of the Analyst 1.4.2 Software 175 
from Applied Biosystems-Sciex (Foster City, California, USA) and a companion 176 
software appendix for controlling the Symbiosis
TM
 Pico from Spark Holland (Emmen, 177 
The Netherlands). 178 
Chromatographic separation of the cytostatic drugs was performed on a reversed-179 
phase column Purospher STAR RP-18e (125 x 2 mm, 5 µm particle size) from Merck, 180 
maintained at 25 ºC. Ultrapure water (A) and methanol (B), both containing 0.1% of 181 
formic acid, were employed as mobile phase (flow-rate 0.2 mL min
-1
). Under final 182 
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optimized conditions, compounds were separated using the following gradient: 0–1 min, 183 
5% B; 2 min, 20% B; 12 min, 80% B; 25–30 min, 100% B; 35–40 min, 5% B.  184 
The mass spectrometer was operated using positive ESI mode under the following 185 
optimized conditions: curtain gas, 10 V; source temperature, 700ºC; nitrogen collision 186 
gas, high; ion spray voltage, 4000 V; ion source gases GS1 and GS2 40 and 60 V, 187 
respectively. Data acquisition was performed in the selected reaction monitoring (SRM) 188 
mode, recording the transitions between the precursor ion and the two most abundant 189 
product ions for each target analyte. Optimized MS/MS ion transitions for each 190 
compound are detailed in Table 1. 191 
 192 
3. Results and discussion 193 
3.1. Optimization of on-line SPE parameters 194 
3.1.1. Preliminary experiments 195 
 In the initial steps of this study, extraction experiments were carried out in amber 196 
vessels which contained 5 µg L
-1
 of spiked cytostatics and TPs (the percentage of 197 
DMSO was lower than 0.5%) in HPLC water. The sample extraction volume was 5 mL 198 
and after loading the sample, the cartridge was washed with 0.5 mL of HPLC water. 199 
The most important parameter to be evaluated in the optimization of a new SPE 200 
procedure is the type of sorbent. Its selection depends basically on the nature of the 201 
matrix and the physical-chemical properties of the target analytes. Fig. 2 shows the 202 
recovery percentages obtained with all five cartridges tested by on-line SPE for 203 
triplicate assays. Extraction efficiencies were calculated from the peak areas obtained in 204 
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the on-line analysis of the water samples as percentages of the peak areas obtained in 205 
the direct chromatographic injection (10 µL) of equivalent amounts of the standard 206 
mixtures in HPLC water (percentage of DMSO ≤ 0.5%). 207 
The GP cartridge showed poor repeatability for some compounds, the HCX and 208 
the C18 cartridges yielded poor recoveries also for some compounds, and Oasis HLB 209 
and PLRP-s were the preferred ones for most analytes. 210 
3.1.2. Multilevel optimization of SPE conditions 211 
 The efficiency of SPE methods is affected by a considerable number of factors, which 212 
are sometimes correlated. A strategy based on the use of a multi-level experimental 213 
design was used to assess the effects of cartridge, sample volume and pH on the 214 
performance of the SPE process, and search for the optimal extraction conditions with a 215 
minimum effort and cost. Low and high values for each of these parameters are given in 216 
Table 2. Previous assays showed better efﬁciencies using PLRP-s and Oasis HLB as 217 
sorbents operating at room temperature; therefore, both cartridges were used in the 218 
design. The spiked level was 5 µg L
-1
. HCl and sodium hidroxide were used for pH 219 
adjustment. 220 
Peak areas obtained for each compound in the 18 extractions involved in the 221 
above design were compared with those obtained from the injection of standards 222 
mixtures, and they were used as variable responses. Standardized values for main 223 
effects corresponding to each factor were calculated with the Statgraphics Centurion 224 
XV software (Manugistics, Rockville, MD, USA). Fig. 3 shows the Pareto Charts for 225 
the compounds that resulted more affected for the conditions of the design. The 226 
metabolites OH-MET, OH-PAC, OH-D-TAM and OH-TAM followed the same 227 
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behaviour than the corresponding parent drugs MET, PAC and TAM. The length of 228 
plotted bars is proportional to the change in the response of a given compound when the 229 
associated factor varies from the low to the high level within the domain of the design. 230 
A positive sign indicates an increase in the observed response, whereas a negative value 231 
shows the opposite effect. The blue vertical lines correspond to the statistic signiﬁcance 232 
limit, established for a 95% conﬁdence level. The pH of the water samples showed a 233 
negative effect on the efﬁciency of the extraction step for almost all compounds being 234 
statistically significant for MET, IMA, DOX, TAM, OH-TAM and OH-D-TAM. The 235 
sample volume played a negative effect and it was statistically significant for the most 236 
polar species (GEM and TMZ), which are eluted while their extraction takes place. The 237 
effect of the sorbent (PLRP-s and Oasis HLB) was not statistically significant for a 95% 238 
conﬁdence level but PLRP-s is preferred for most compounds. Two-factor interactions 239 
played inﬂuence on the SPE process; therefore additional experiments were carried out 240 
to corroborate the result. Fig. 4 shows the results for HPLC-water at pH 2 and 6, spiked 241 
at 5 µg L
-1
, using the PLRP-s cartridge and 5 mL of sample in triplicate. In other series 242 
of experiments 5 mL and 10 mL of HPLC water adjusted to pH 2 were compared in 243 
triplicate (see Fig. 5). As it can be seen in the above Figures, some compounds (IMA, 244 
TAM, OH-D-TAM and OH-TAM) were not efficiently extracted at pH 6 (Fig. 4), and 5 245 
mL of sample extraction volume presented better recoveries than 10 mL (see Fig. 5). 246 
The most polar compounds (GEM and TMZ) presented a very low response with both 5 247 
and 10 mL. However, if the sample extraction volume is reduced, the extraction 248 
efficiency of the rest of compounds becomes worse; therefore 5 mL adjusted at pH 2 249 
and extracted with a PLRP-s cartridge were selected as optimal conditions for further 250 
experiments. 251 
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The washing step was not optimized due to the high polarity of some of the target 252 
compounds. Polar species can be easily eluted from the cartridge with water or if the 253 
content of methanol is increased. So, 0.5 mL of water was considered to be the optimum 254 
volume to wash the cartridge without losing the analytes and was therefore selected for 255 
all experiments. 256 
3.2. Method performance 257 
The method performance was evaluated through estimation of the linearity, 258 
repeatability, accuracy and sensitivity of the method. 259 
Quantification, based on peak areas, was performed by the isotope dilution 260 
method. For each target analyte, except for DOX and TAM, isotope-labelled analogues 261 
were available and were thus used as IS (see section Standards and solvents). In the 262 
absence of appropriate isotopically labelled IS for DOX and TAM their quantification 263 
was performed with the closely eluting compounds erlotinib-d6 hydrochloride and 4-264 
hydroxy-ethyl-tamoxifen-d5, respectively. 265 
The linearity of the method was investigated with standards prepared in HPLC 266 
water at eight different concentrations, from 1 ng L
-1
 (or the limit of quantification if 267 
higher) to 5000 ng L
-1
 (1, 5, 10, 50, 100, 500, 1000 and 5000 ng L
-1
). The concentration 268 
of the IS was in all cases 500 ng L
-1
. Within the above range, both the SRM1 and the 269 
SRM2 signals versus the concentration of each analyte fitted a linear model with R
2
 270 
values higher than 0.99 for all compounds (see Table 3). 271 
The method limits of detection (LODs) and quantification (LOQs) were 272 
experimentally estimated from the online analysis of spiked HPLC water (lowest level 273 
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included in the calibration curve) as the concentration of analyte giving a signal-to-noise 274 
ratio (S/N) of 3 and 10, respectively. Table 3 shows the method LODs and limits of 275 
determination (LDet, minimum concentration of a compound that can be quantified 276 
(>LOQ, SRM1) and confirmed (>LOD, SRM2)). LODs were in the picogram per liter 277 
range for all compounds except IMA (22 ng L
-1
) and ETP (3.0 ng L
-1
). These 278 
comparatively higher LODs for IMA and ETP are the result of an inefficient ionization 279 
in the ESI interface. Meanwhile, the limits of determination (LDets) varied between 0.3 280 
and 3 ng L
-1
 for all compounds except GEM (6.9 ng L
-1
), TMZ (21 ng L
-1
), IMA (75 ng 281 
L
-1
) and ETP (38 ng L
-1
). Due to the similarity of responses obtained with the two SRM 282 
transitions selected for quantification and confirmation of each analyte (SRM1/SRM2 283 
ratio lower than 7 for all compounds except TMZ (24.3), ETP (26.0) and OH-D-TAM 284 
(15.8)), the LDets coincide with the LOQs in most instances and remain fairly low. 285 
The precision of the method was evaluated for n=5 extractions of HPLC water 286 
fortified at three different concentrations: 20, 500 and 5000 ng L
-1
. Relative standard 287 
deviations (RSDs) were in all cases below 15%, with the single exception of the 20% 288 
RSD obtained for IMA when fortified at 500 ng L
-1
 (see Table 3). This satisfactory 289 
repeatability is possible with automated procedures such as that described here where 290 
manipulation of the sample is reduced to its filtration, pH adjustment, and addition of 291 
IS. 292 
Absolute recoveries calculated by comparing with the standard injected in off-line 293 
mode were above 70% for all compounds except GEM, TMZ, IMA and ETP (see Table 294 
3). Relative recoveries calculated with respect to the IS were within the margin 100 ± 295 
30% for all compounds except IMA (58%). 296 
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The influence of matrix effects in quantitative LC-MS/MS analysis is a widely 297 
observed and studied phenomenon. In order to evaluate the degree of ion suppression or 298 
enhancement for each target compound, matrix effects in different water matrices 299 
(groundwater (GW), surface water (SW), wastewater influent (WWI) and wastewater 300 
effluent (WWE)) were evaluated by comparing the peak areas of the analytes in spiked 301 
real samples (after subtracting the peak areas corresponding to the native analytes 302 
present in the sample) with those obtained in spiked HPLC water. Fig. 6 shows the 303 
results obtained for the samples spiked at 500 ng L
-1
 (n=5). In the case of GW, the 304 
recoveries were between 86 and 119%; however, in the other, more complex matrices 305 
(SW and WW) a reduced response was observed for some compounds. The reduction in 306 
the efﬁciency of the ionization of the target species in the more complex matrix, WWI, 307 
varied between 10% for MET and 73% for DOX, while GEM, OH-PAC and PAC 308 
showed some signal enhancement. It is also interesting to note that the results in the SW 309 
sample are fairly similar to those of the WW samples, which is due to the origin of the 310 
SW sample: a highly polluted Mediterranean river localized in the NE of Spain 311 
(Llobregat). On the other hand, for the purpose of evaluating the eventual correction 312 
and/or minimization of matrix effects through sample dilution the aqueous matrices 313 
were diluted 1:1 with HPLC water. For OH-MET, IMA, IRI and ETP, dilution of the 314 
samples led to a reduction of the signal suppression by about 20%, but for most 315 
compounds the problem was not solved. Therefore, the use of isotopically labelled 316 
compounds for quantification is nearly indispensable in order to obtain accurate results 317 
in complex matrices. 318 
Table 4 shows the recoveries of the method for the four matrices at three 319 
fortification levels, 20, 500 and 5000 ng L
-1
 (n=5), after correcting the responses of the 320 
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analytes with the corresponding IS. Corrected recoveries ranged from 72 ± 3% to 119 ± 321 
5% for all compounds. 322 
The repeatability of the method was also evaluated in the four aforementioned 323 
matrices, and the results obtained showed good repeatability, with relative standard 324 
deviations (RSDs) in most instances below 15%, even in the most complex matrix 325 
(WWI) (see Table 4). 326 
As regards the sensitivity, Table 5 lists the method LODs and LDets in each 327 
matrix. As it can be seen, the LODs were between 0.2 and 1.6 ng L
-1
 and the LDets 328 
between 0.4 and 5.0 ng L
-1
. The exceptions were GEM (with LODs between 0.2 and 0.7 329 
ng L
-1
 and LDets between 6.9 and 9.3 ng L
-1
), TMZ (with LODs between 0.8 and 1.1 ng 330 
L
-1
 and LDtes LDets between 26 and 50 ng L
-1
), IMA (with LODs between 24 and 54 331 
ng L
-1
 and LDtes LDets between 80 and 180 ng L
-1
), and ETP (with LODs between 3.0 332 
and 19.5 ng L
-1
 and LDtes LDets between 38 and 65 ng L
-1
), i.e., the compounds 333 
presenting the worst SPE efficiency. Fig. 7 shows, for illustration, a chromatogram of a 334 
groundwater sample spiked with the compounds at 20 ng L
-1
. 335 
Overall, the method limits of determination obtained in wastewater are lower or in 336 
the same range of those reported for by other authors [15-16,23-24]. There are no 337 
method detection limits reported for TMZ, IMA, ERL, CAP, OH-TAM, OH-D-TAM 338 
and OH-PAC in environmental samples. 339 
Finally, for positive confirmation of the presence of a compound in a sample, the 340 
LC retention of the compound in the sample must match that of the standard with a 341 
margin of ± 2%, and its SRM1/SRM2 ratio cannot deviate more than 20-50% 342 
(depending on the SRM1/SRM2 value) from the ratio in the standard [29]. 343 
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 344 
3.3. Application to real water samples 345 
As a part of the validation procedure, the method developed was applied to the 346 
analysis of the target analytes in various wastewater samples collected daily during 8 347 
consecutive days (in April 2012) from the inlet of a WWTP located in Catalonia. Time-348 
proportional sampling, collecting 50 mL of sample every 10 min, for a daily total 349 
sample volume of 7.2 L, was carried out with the help of an ISCO 6172 FR Stationary 350 
system (Instrumentación analítica, El Prat de Llobregat, Barcelona, Spain). Upon 351 
collection the sample was homogenized by manual agitation and an aliquot (1 L) was 352 
transferred to an amber PET bottle and transported to the laboratory. During collection 353 
and during transport the samples were maintained refrigerated at 4 °C and protected 354 
from light. Once at the laboratory the samples were filtered and subsequently stored at -355 
20 °C until analysis. 356 
At the time of analysis, quality control (QC) samples (HPLC water spiked with 357 
the analytes at 100 ng L
-1
) were run in between samples. Potential contamination 358 
problems were evaluated with procedural blanks (plain HPLC water). 359 
The results obtained (see Table 6) showed the presence of CAP and MET in all 360 
samples at concentrations between 2.1 ng L
-1
 for MET and 30 ng L
-1
 for CAP. IF and 361 
TAM were also found in several samples at concentrations up to 43 and 17 ng L
-1
, 362 
respectively. OH-PAC was detected in only one sample at a level of 4.4 ng L
-1
, while 363 
the rest of compounds remained below the quantification limits reported in Table 5.  364 
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IF had been previously found in wastewater samples from Germany at levels similar to 365 
those reported in the present study [15], and at considerably higher concentrations in a 366 
hospital effluent from China where IF and MET reached values around 11000 and 3000 367 
ng L
-1
, respectively [19]. On the other hand, to the best of the authors’ knowledge, this 368 
study constitutes the first evidence of the presence of CAP and TAM in water samples. 369 
 370 
4. Conclusions 371 
The method developed, based on on-line SPE-LC-MS/MS, allows the 372 
simultaneous multi-analyte determination of most the target compounds at the pg or low 373 
ng L
-1
 level in GW, SW, WWE and WW. Some compounds are affected by matrix 374 
ionization effects; hence, the use of isotopically labelled compounds as IS for accurate 375 
quantification is required.. On the other hand, the performance of the SPE process 376 
entirely in parallel with the LC-MS/MS run allows to achieve analysis times per sample 377 
of only 40 min). The analysis of composite wastewater samples from the inlet of a 378 
WWTP showed the presence of only 5 of the compounds investigated (MET, IF, CAP, 379 
TAM and OH-PAC) and at fairly low concentrations (between 2.1 and 43 ng L
-1
). 380 
However, health effects cannot be discarded. For this reason, sensitivity is of utmost 381 
importance. To the best of the authors’ knowledge, this method constitutes the first 382 
multiresidue method based on on-line SPE developed for the determination of 383 
cytostatics in the aquatic environment. Moreover, temozolomide, imatinib, erlotinib, 384 
capecitabine, hydroxytamoxifen, desmethyl-hydroxytamoxifen and hydroxypaclitaxel 385 
have not been included in previously optimized methods for environmental samples. 386 
 387 
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Captions to figures 457 
Fig. 1. Structures and log Kow of the target compounds.
 
458 
Fig. 2. Comparison of the recovery percentages and corresponding standard deviations 459 
obtained for the various target analytes in the replicate (n = 3) on-line SPE-LC-MS/MS 460 
analysis of spiked (5 μg L-1) HPLC water with different SPE cartridges (extraction 461 
volume 5 mL, wash volume 0.5 mL). 462 
Fig. 3. Standardized Pareto chart showing the main effects of cartridge, sample volume 463 
and pH on the performance of the extraction step for the compounds that resulted more 464 
affected by the conditions tested in the design.  465 
Fig. 4. Influence of the sample pH on the on-line SPE efficiency (PLRP-s cartridge, 5 466 
mL sample volume, wash volume 0.5 mL, n=3). 467 
Fig. 5. Comparison of the recovery percentages and corresponding standard deviations 468 
obtained for the various target analytes in the replicate (n = 3) on-line SPE-LC-MS/MS 469 
analysis of 5 and 10 mL of spiked (5 μg L-1) HPLC water. 470 
Fig. 6. Matrix effects in groundwater, surface water and wastewater (effluent and 471 
influent). 472 
Fig. 7. SRM chromatograms corresponding to the analysis of a groundwater sample 473 
spiked with the analytes at 20 ng L
-1
. 474 
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Table 1 
Specific SRM Conditions for Determination of Cytostatics. 
Compound 
tR
a
 
(min) 
Seg
b
 
DP
c
 
(V) 
CE
d
 
(eV) 
MS/MS 
transition 
Corresponding 
IS 
SRM ratio 
(SRM1/SRM2) 
GEM 3.6 1 71 
25 264.2 > 112.0 267.0 > 115.0 
6.8 ± 0.9 
63 264.2 > 95.0 267.0 > 97.0 
TMZ 5.4 2 26 
9 195.0 > 138.0 197.8 > 138.0 
24.3 ± 2.5 
13 195.0 > 67.2 197.8 > 54.9 
MET 7.2 2 91 
33 455.2 > 308.2 458.2 > 311.1 
1.8 ± 0.8 
59 455.2 > 175.1 458.2 > 175.1 
OH-MET 8.7 3 36 
37 471.1 > 191.1 474.0 > 327.1 
1.1 ± 0.1 
15 471.1 > 324.2 474.0 >191.0 
IMA 10.9 3 116 
37 494.3 > 394.2 488.2 > 394.2 
2.9 ± 0.3 
35 494.3 > 217.2 488.2 > 211.1 
IRI 10.2 3 66 
51 587.4 >124.1 598.2 > 133.1 
1.2 ± 0.1 
57 587.4 >167.2 598.2 > 177.2 
IF 10.7 3 81 
35 261.1 > 92.0 266.0 > 157.0 
1.3 ± 0.2 
31 261.1 > 154.0 266.0 > 187.0 
CP 11.2 3 86 
33 261.1 > 140.0 264.9 > 140.0 
2.4 ± 0.2 
25 261.1 > 106.1 264.9 > 106.0 
ERL 11.2 3 81 
45 394.2 > 278.1 400.2 > 278.0 
1.5 ± 0.2 
33 394.2 > 336.3 400.2 > 339.1 
ETP 11.5 3 71 
15 589.0 > 229.0 592.3 > 229.0 
26.0 ± 2.1 
10 589.0 > 185.0 592.3 > 185.1 
DOX 12.6 3 81 
17 544.3 > 397.1 400.2 > 278.0 
3.4 ± 0.2 
37 544.3 > 361.0 400.2 > 339.1 
CAP 12.9 3 101 
17 360.2 > 244.2 371.0 > 255.2 
2.2 ± 0.2 
29 360.2 > 174.1 371.0 > 175.0 
OH-D-TAM 13.1 3 56 
45 374.1 > 58.1 379.1 > 58.0 
15.8 ± 1.6 
37 374.1 > 129.1 379.1 >228.1 
OH-TAM 13.2 3 91 
51 388.2 > 72.1 393.1 > 72.0 
6.9 ± 0.6 
89 388.2 > 44.1 393.1 > 45.0 
TAM 14.5 4 91 
49 372.3 > 72.1 393.1 > 72.0 
6.3 ± 0.8 
91 372.3 > 44.1 393.1 > 45.0 
OH-PAC 14.7 4 111 
23 870.5 > 286.1 876.4 > 291.1 
2.6 ± 0.3 
15 870.5 > 525.4 876.4 > 526.2 
PAC 15.0 4 61 
95 854.5 > 105.1 860.0 > 105.0 
0.7 ± 0.2 
25 854.5 > 286.2 860.0 > 291.1 
a 
Retention time (min). 
b
 Segment. 
c
 Declustering potential. 
d
 Collision energy.
Tables
Table 2 
Experimental Domain of the Multi-level Design. 
Factor 
Level 
Low (-) Medium High (+) 
A: Cartridge PLRP-s - Oasis HLB 
B: Sample volume (mL) 1 5 20 
C: pH 2 6 8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 3 
Quality Control Parameters of the Analytical Method: Linear Estimation Coefficients (r
2
), LOD, 
Limits of Determination (LDet), Repeatability (RSD), and Absolute (AR) and Relative 
Recoveries (RR) in HPLC Water. 
 
Compound 
Linearity 
r
2
 
LOD
a
 
(ng L
-1
) 
LDet
b
 
(ng L
-1
) 
Repeatability (%) n=5 
AR
d
 (%) RR
e
 (%) 20
c
  
ng L
-1
 
500
c
  
ng L
-1
 
5000
c
  
ng L
-1
 
GEM 0.9999 0.3 6.9 8.7 7.6 14 0.13 ± 0.02 106 ± 9 
TMZ 0.9934 0.7 21 6.2 7.5 9.0 18 ± 4 110 ± 6 
MET 0.9970 0.1 0.5 9.9 4.2 2.9 99 ± 12 116 ± 7 
OH-MET 0.9995 0.2 0.7 8.9 6.2 1.7 111 ± 5 97 ± 7 
IRI 0.9996 0.1 0.4 7.2 1.2 2.5 91 ± 2 93 ± 7 
IMA 0.9945 22 75 - 20 10 54 ± 15 58 ± 9 
IF 0.9996 0.2 0.8 3.8 2.9 14 119 ± 4 81 ± 3 
CP 0.9998 0.1 0.4 2.3 1.7 2.3 109 ± 6 104 ± 5 
ERL 0.9989 0.1 0.3 4.2 1.2 10 97 ± 1 98 ± 3 
ETP 0.9981 3.0 38 14 12 15 36 ± 17 73 ± 11 
DOX 0.9997 0.1 1.8 6.5 2.6 3.3 75 ± 12 86 ± 10 
CAP 0.9989 0.2 1.3 7 5.2 4.0 107 ± 12 99 ± 5 
OH-D-TAM 0.9986 0.3 1.8 2.7 7.5 11 91 ± 11 84 ± 12 
OH-TAM 0.9991 0.06 0.5 6.4 5.8 8.3 114 ± 10 91 ± 4 
TAM 0.9978 0.3 1.0 8.6 10 11 83 ± 7 96 ± 11 
OH-PAC 0.9990 0.4 3.0 14 5.6 6.9 77 ± 7 96 ± 2 
PAC 0.9999 0.6 3.0 15 2.2 3.6 73 ± 17 75 ± 3 
         a 
Limit of detection (defined as a S/N 3) of the first SRM transition. 
b 
Limit of determination: 
minimum concentration that can be quantified (>LOQ, SRM1) and confirmed (>LOD, SRM2). c 
Spiked level. 
d 
Calculated from the peak areas obtained in the on-line analysis of spiked (500 ng 
L
-1
) HPLC water as percentages of the peak areas obtained from direct chromatographic 
injection (10 µL) of equivalent amounts of the standards in HPLC water (mean of the average 
results obtained at each concentration). 
e
 Relative to the associated IS. -not quantifiable 
 
 
Table 4 
Relative recoveries (n=5 replicates) calculated in Four Different Water Matrices (Groundwater, Surface Water, Wastewater Effluent and Wastewater Influent) 
spiked with the Analytes at Three Different Concentrations (20, 500, and 5000 ng L
-1
). 
Compound 
Average recovery (%) ± relative standard deviation 
GW SW WWE WWI 
a20 ng L-1 a500 ng L-1 a5000 ng L-1 a20 ng L-1 a500 ng L-1 a5000 ng L-1 a20 ng L-1 a500 ng L-1 a5000 ng L-1 a20 ng L-1 a500 ng L-1 a5000 ng L-1 
GEM 
TMZ 
MET 
OH-MET 
IMA 
IRI 
IF 
CP 
ERL 
ETP 
DOX 
CAP 
OH-D-TAM 
OH-TAM 
TAM 
OH-PAC 
PAC 
116 ± 10 
112 ± 3 
90 ± 12 
91 ± 11 
nq 
119 ± 5 
114 ± 1 
115 ± 12 
110 ± 16 
104 ± 16 
72 ± 8 
84 ± 11 
109 ± 12 
108 ± 15 
110 ± 14 
93 ± 22 
117 ± 10 
90 ± 1 
86 ± 5 
96 ± 4 
103 ± 2 
88 ± 15 
90 ± 6 
100 ± 3 
97 ± 2 
96 ± 2 
102 ± 17 
96 ± 8 
89 ± 3 
100 ± 5 
103 ± 5 
119 ± 16 
97 ± 8 
104 ± 7 
103 ± 3 
98 ± 5 
88 ± 3 
96 ± 3 
77 ± 15 
96 ± 5 
107 ± 8 
96 ± 4 
94 ± 5 
111 ± 9 
94 ± 11 
91 ± 6 
97 ± 7 
109 ± 8 
84 ± 13 
81 ± 11 
72 ± 13 
108 ± 13 
103 ± 15 
84 ± 8 
85 ± 25 
nq 
104 ± 7 
101 ± 12 
104 ± 13 
95 ± 5 
nq 
78 ± 5 
105 ± 15 
98 ± 4 
76 ± 9 
92 ± 4 
113 ± 11 
99 ± 14 
115 ± 12 
98 ± 13 
103 ± 3 
113 ± 5 
109 ± 7 
96 ± 5 
101 ± 3 
100 ± 3 
109 ± 1 
98 ± 2 
74 ± 10 
105 ± 9 
81 ± 2 
84 ± 4 
92 ± 1 
94 ± 9 
107 ± 7 
99 ± 4 
97 ± 4 
92 ± 2 
75 ± 10 
103 ± 15 
97 ± 3 
89 ± 3 
83 ± 4 
100 ± 4 
77 ± 12 
94 ± 1 
92 ± 5 
74 ± 4 
92 ± 6 
81 ± 9 
108 ± 9 
93 ± 10 
96 ± 15 
98 ± 12 
87 ± 15 
88 ± 14 
nq 
82 ± 2 
107 ± 13 
115 ± 12 
91 ± 2 
nq 
98 ± 10 
107 ± 8 
76 ± 5 
89 ± 4 
101 ± 2 
92 ± 11 
102 ± 2 
93 ± 1 
94 ± 2 
99 ± 1 
88 ± 1 
111 ± 6 
95 ± 2 
95 ± 2 
96 ± 2 
95 ± 1 
94 ± 4 
95 ± 5 
104 ± 12 
99 ± 17 
99 ± 11 
117 ± 1 
94 ± 10 
99 ± 1 
104 ± 5 
100 ± 4 
102 ± 2 
89 ± 2 
91 ± 4 
107 ± 3 
93 ± 4 
93 ± 1 
108 ± 4 
76 ± 1 
101 ± 2 
104 ± 3 
60 ± 3 
80 ± 4 
105 ± 10 
112 ± 4 
108 ± 6 
96 ± 2 
95 ± 12 
94 ± 14 
83 ± 5 
nq 
72 ± 11 
92 ± 4 
102 ± 11 
111 ± 12 
nq 
75 ± 4 
88 ± 8 
79 ± 14 
103 ± 12 
104 ± 11 
113 ± 6 
108 ± 12 
114 ± 2 
103 ± 4 
104 ± 8 
99 ± 2 
108 ± 10 
88 ± 1 
107 ± 1 
99 ± 1 
111 ± 1 
81 ± 3 
71 ± 1 
119 ± 12 
96 ± 7 
100 ± 8 
107 ± 2 
111 ± 9 
101 ± 7 
110 ± 9 
107 ± 1 
87 ± 9 
99 ± 4 
120 ± 11 
82 ± 2 
96 ± 11 
102 ± 3 
114 ± 5 
106 ± 7 
76 ± 1 
95 ± 8 
104 ± 6 
114 ± 13 
105 ± 4 
93 ± 13 
113 ± 9 
Abreviations: GW, groundwater; SW, surface water, WWE, wastewater effluent; WWI, wastewater influent; nq, not quantifiable. 
a
Spiked level  
Table 5 
 LODs and LDets in Groundwater (GW), Surface water (SW), and Wastewater Effluent (WWE) 
and Influent (WWI). 
Compound 
LOD (ng L-1)  Ldet (ng L-1) 
GW SW WWE WWI  GW SW WWE WWI 
GEM 0.2 0.7 0.7 0.7  6.9 9.3 9.3 9.3 
TMZ 0.8 0.9 1.0 1.1  26 50 42 50 
MET 0.2 0.6 0.5 0.6  0.5 2.0 1.8 2.0 
OH-MET 0.2 1.3 1.3 1.6  0.7 4.3 4.3 5.2 
IRI 0.1 0.4 0.4 1.4  0.4 1.3 1.2 4.5 
IMA 24 45 36 54  80 150 120 180 
IF 0.3 0.6 0.6 0.6  1.0 2.0 2.0 2.0 
CP 0.2 0.6 0.5 0.6  0.8 2.0 1.5 3.0 
ERL 0.2 0.7 1.0 0.5  0.5 2.3 3.4 1.7 
ETP 3.0 13 12 20  38 43 40 65 
DOX 0.2 0.7 0.7 0.8  1.8 2.4 2.4 2.5 
CAP 0.3 0.5 0.5 0.7  2.5 3.5 3.5 5.0 
OH-D-TAM 0.3 1.5 1.5 1.5  1.8 5.0 5.0 5.0 
OH-TAM 0.2 0.3 0.3 0.7  0.6 1.0 1.1 5.0 
TAM 0.3 0.7 0.9 1.0  1.0 2.3 3.0 3.4 
OH-PAC 0.6 0.9 1.1 1.1  3.0 2.9 3.6 3.6 
PAC 0.5 0.9 1.2 1.3  3.0 3.1 4.0 4.4 
Table 6 
Levels of Detected Cytostatics in Raw Wastewater. 
 
  Concentration (ng L-1)  
Code Collection date MET IF CAP TAM OH-PAC 
1 17-18/04/2012 7.8 nq 24.7 nq 4.4 
2 18-19/04/2012 2.1 43.3 20.0 4.4 nd 
3 19-20/04/2012 2.4 29.7 27.0 17.2 nd 
4 20-21/04/2012 20.1 13.5 9.7 nd nd 
5 21-22/04/2012 6.9 7.3 8.2 nd nd 
6 22-23/04/2012 4.1 nq nq 4.3 nd 
7 23-24/04/2012 4.8 nq 21.0 nd nd 
8 24-25/04/2012 2.2 nq 14.3 3.5 nd 
nq, below LDet; nd, below LOD 
